OASYS NOW is a European health-tech startup dedicated to making personalized healthcare accessible to all. By leveraging certified, privacy-first AI technology, OASYS NOW transforms unstructured medical data into actionable insights, significantly accelerating patient identification for clinical trials. This innovation reduces the time required to match patients from months to mere minutes, thereby expediting the development of life-saving treatments. Key Features and Functionality: - ELaiGIBLE CT: An AI-powered pre-screening tool that automatically reads study protocols and scans various patient data formats, including electronic health records (EHRs) and PDFs, in real-time. It provides traceable, evidence-based results to support dynamic screening tasks. - De-ID: A certified de-identification solution designed for both structured and unstructured health data. It detects sensitive information in diverse formats such as PDFs, scans, clinical notes, and handwriting, enabling secure anonymization or pseudonymization in compliance with GDPR and EHDS standards. - GRIP: A platform that facilitates the secure collection, enrichment, and connection of real-world health and lifestyle data directly from patients, all under dynamic consent. It offers features like dynamic consent management, patient-reported outcome measures (PROM) tracking, and robust data governance and linkage capabilities. - CoMPai: A confidential multi-party AI framework that enables cross-border data collaboration without the need to access or transfer raw data. It supports confidential aggregation, is compatible with genomic data formats, and ensures performance-preserving privacy. Primary Value and User Solutions: OASYS NOW addresses critical challenges in clinical trial recruitment by automating and streamlining the patient identification process. Traditional methods are often time-consuming and inefficient, delaying the development of essential treatments. By utilizing AI to analyze unstructured medical data, OASYS NOW significantly reduces the time required to match patients with appropriate clinical trials, thereby accelerating research and improving patient outcomes. Additionally, the company's commitment to data privacy and compliance ensures that sensitive health information is handled securely, fostering trust among healthcare providers and patients alike.